Apollo Hospitals Enterprise Share PriceApollo Hospitals Enterprise

93.95 (1.72%)
  • Advice
  • Hold
As on 09 December, 2023 | 00:34 BSE: 508869 NSE: APOLLOHOSPISIN: INE437A01024

Apollo Hospitals Enterprise Performance

Day Range

  • Low 5,439.05
  • High 5,572.55
₹ 5,555.35

52 Week Range

  • Low 4,123.00
  • High 5,689.00
₹ 5,555.35
  • Open Price5,495.00
  • Previous Close5,461.40
  • Volume456382

Start SIP in Apollo Hospitals Enterprise

Start SIP

Apollo Hospitals Enterprise Share Price

  • Over 1 Month 8.7%
  • Over 3 Month 11.44%
  • Over 6 Month 12.76%
  • Over 1 Year 18.09%

Apollo Hospitals Enterprise Key Statistics

P/E Ratio 114.5
PEG Ratio -6.8
Market Cap Cr 79,877
Price to Book Ratio 12.2
EPS 74.6
Dividend 0.3
Relative Strength Index 61.77
Money Flow Index 58.52
MACD Signal 118.12
Average True Range 115.95

Apollo Hospitals Enterprise Investment Rating

  • Master Rating:
  • Apollo Hosps.Enterprise has an operating revenue of Rs. 17,830.48 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 7% is okay, ROE of 13% is good. The company has a reasonable debt to equity of 31%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 12% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 5% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 76 which is a FAIR score but needs to improve its earnings, a RS Rating of 45 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Apollo Hospitals Enterprise Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1,8671,6881,6411,6391,7161,5301,421
Operating Expenses Qtr Cr 1,3871,2711,2181,2221,2631,1411,089
Operating Profit Qtr Cr 479418423417453388332
Depreciation Qtr Cr 939397899289105
Interest Qtr Cr 60616160586058
Tax Qtr Cr 9667827866-8340
Net Profit Qtr Cr 295214227246279333154
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 6,6766,145
Operating Expenses Annual Cr 4,8434,679
Operating Profit Annual in Cr 1,6821,419
Depreciation Cr 367363
Interest Annual Cr 239244
Tax Annual Cr 143280
Net Profit Annual Cr 1,085665
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1,2251,201
Cash from Investing Activity Annual Cr -589-445
Cash from Financing Annual Activity Cr -779-637
Net Cash Flow Annual Cr -143119
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 6,9256,111
Fixed Assets Annual Cr 5,1745,145
Total Non Current Assets Annual Cr 7,6306,953
Total Current Assets Annual Cr 3,1513,455
Total Assets Annual Cr 10,78010,408
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 482425
ROE Annual % 1611
ROCE Annual % 1512
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2824
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 4,8474,4184,3024,2644,2513,7963,546
Operating Expenses Qtr Cr 4,2193,9093,8143,7583,6863,3053,083
Operating Profit Qtr Cr 628509488505565491463
Depreciation Qtr Cr 163167159153155148166
Interest Qtr Cr 11110695100939395
Tax Qtr Cr 13097108104114-70139
Net Profit Qtr Cr 23316714515320431790
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 16,70314,741
Operating Expenses Annual Cr 14,56312,478
Operating Profit Annual in Cr 2,0502,185
Depreciation Cr 615601
Interest Annual Cr 381379
Tax Annual Cr 256477
Net Profit Annual Cr 8191,056
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1,3771,628
Cash from Investing Activity Annual Cr -871-778
Cash from Financing Annual Activity Cr -633-793
Net Cash Flow Annual Cr -12757
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 6,1975,623
Fixed Assets Annual Cr 8,1447,391
Total Non Current Assets Annual Cr 10,0919,071
Total Current Assets Annual Cr 4,3374,122
Total Assets Annual Cr 14,42813,192
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 454409
ROE Annual % 1319
ROCE Annual % 1415
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1315

Apollo Hospitals Enterprise Technicals


Current Price
93.95 (1.72%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹5,426.50
  • 50 Day
  • ₹5,257.52
  • 100 Day
  • ₹5,119.87
  • 200 Day
  • ₹4,934.66
  • 20 Day
  • ₹5,442.84
  • 50 Day
  • ₹5,184.85
  • 100 Day
  • ₹5,101.00
  • 200 Day
  • ₹4,867.88

Apollo Hospitals Enterprise Resistance and Support

First Resistance 5,605.58
Second Resistance 5,655.82
Third Resistance 5,739.08
RSI 61.77
MFI 58.52
MACD Single Line 118.12
MACD 112.67
First Resistance 5,472.08
Second Resistance 5,388.82
Third Resistance 5,338.58

Apollo Hospitals Enterprise Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 463,881 25,434,595 54.83
Week 661,319 41,676,336 63.02
1 Month 503,464 25,047,348 49.75
6 Month 466,167 23,201,108 49.77

Apollo Hospitals Enterprise Result Highlights

Apollo Hospitals Enterprise Synopsis


Apollo Hospitals is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 6524.80 Cr. and Equity Capital is Rs. 71.90 Cr. for the Year ended 31/03/2023. Apollo Hospitals Enterprise Ltd. is a Public Limited Listed company incorporated on 05/12/1979 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TN1979PLC008035 and registration number is 008035.
Market Cap 79,657
Sales 6,834
Shares in Float 10.21
No of funds 1336
Yield 0.27
Book Value 11.5
U/D Vol ratio 0.9
LTDebt / Equity 22
Alpha 0.03
Beta 0.58

Apollo Hospitals Enterprise

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 29.33%29.33%29.33%29.33%
Mutual Funds 13.19%12.04%11.37%10.2%
Insurance Companies 4.28%4.23%5.49%5.52%
Foreign Portfolio Investors 46.15%47.93%46.96%47.94%
Financial Institutions/ Banks 0.04%0.11%
Individual Investors 4.03%3.89%4.05%4.13%
Others 3.02%2.54%2.69%2.88%

Apollo Hospitals Enterprise Management

Name Designation
Dr. Prathap C Reddy Founder & Executive Chairman
Mrs. Preetha Reddy Executive Vice Chairperson
Mrs. Shobana Kamineni Executive Vice Chairperson
Mrs. Suneeta Reddy Managing Director
Mrs. Sangita Reddy Joint Managing Director
Mr. M B N Rao Independent Director
Mr. Vinayak Chatterjee Independent Director
Dr. Som Mittal Independent Director
Mrs. V Kavitha Dutt Independent Director
Dr. Murali Doraiswamy Independent Director
Mrs. Rama Bijapurkar Independent Director

Apollo Hospitals Enterprise Forecast

Price Estimates


Other Analyst Rating

Apollo Hospitals Enterprise Corporate Action

Date Purpose Remarks
2023-11-09 Quarterly Results
2023-08-11 Quarterly Results
2023-05-30 Audited Results & Final Dividend
2023-02-14 Quarterly Results & Interim Dividend
2022-11-30 Others Inter-alia, to consider and approve the issuance of unsecured Non-Convertible Debentures on private placement basis. per share(120%)Dividend (Revised)
Date Purpose Remarks
2023-08-19 FINAL Rs.9.00 per share(180%)Final Dividend
2023-02-24 FINAL Rs.6.00 per share(120%)Interim Dividend

Apollo Hospitals Enterprise MF Shareholding

Name Amount(cr)
SBI Nifty 50 ETF 155,471
HDFC Balanced Advantage Fund Growth 63,981
ICICI Prudential Balanced Advantage Fund Growth 49,871
UTI Nifty 50 Exchange Traded Fund 42,363
HDFC Flexi Cap Fund Growth 42,271

About Apollo Hospitals Enterprise

Company Brief

Widely known for operating a nationwide legendary chain of hospitals, the Apollo group is a modern healthcare giant that also runs several diagnostic centres, pharmacies and telehealth clinics under its umbrella. Over the years, the group has forayed into other non-core healthcare domains like health insurance, medical colleges and medvarsity, nursing and hospital management, global projects consultancy and research. 
The prominent brands under its roof include Apollo Munich Health Insurance, Apollo Pharmacy, Life Studio, Apollo Spectra, and Apollo Cradle, besides Apollo Clinic and Hospitals.

Apollo Hospitals was founded by Dr Prathap C Reddy, with its first-ever branch established in Chennai in 1983 and inaugurated by the then president Shri Giani Zail Singh. In the 1980's it had declared its maiden dividend of 10% and established a branch in Hyderabad. Since then, it has set up numerous branches in New Delhi, Bangalore, Kolkata, Mumbai, Noida, Ahmedabad, and Bhubaneshwar, among other Indian cities. It also has a branch in Dhaka, Bangladesh.
One of its early trailblazing endeavours was telemedicine services in 2000 at Aragonda village in Chittoor, Andhra Pradesh. In 2012, 38% stake of the group's healthcare BPO segment was disposed off to Sutherland Global Services at a valuation of INR 225 crores. Further, in early 2020, the majority stake of its insurance subsidiary Apollo Munich Health Insurance was acquired by HDFC for INR 1,495.81 crores.
Over the years, the group has earned multiple international recognitions in healthcare standards, biotechnological breakthroughs and innovative medical care. It has 8 JCIA and 30 NABH (National Accreditation Board for Hospitals) accredited hospitals, not to mention its state-of-the-art speciality wings, including 25 Heart institutes, several cancer hospitals and organ transplant centres.

Board, Management and Auditors

Board of Directors

The board of directors manages the group in the parent company under the able leadership of founder chairman Dr Prathap Chandra Reddy - a Padma Bhushan and Padma Vibhushan awardee. The board consists of:

Executive Director - Prathap C. Reddy 

Dr Reddy is the visionary founder of the Apollo enterprise, responsible for ushering in an era of world-class medical facilities and treatments in India. He is the torchbearer of modern healthcare in this country and is the driving force behind the group's success.

Executive Vice Chairperson - Dr Preetha Reddy

A member of the founding family Dr Reddy is known for her immense contribution to the furtherance of the Apollo group and the betterment of the country through her philanthropic ventures and able governance.

 Executive Vice Chairperson - Ms Shobana Kamineni

Another member of the founding family has advocated the operation of integrated digital-first healthcare services in the country through Apollo 24/7. Presently Ms Kamineni leads the country's largest pharmacy chain, Apollo Pharmacy, with a countrywide network of over 4,000+ stores and 30,000+ employees.

Ms Suneeta Reddy -  Managing Director

Ms Reddy is at the forefront of the group's finance and strategy functions and serves on various subsidiaries' boards.

Dr Sangita Reddy- Joint Managing Director

As a joint MD, Dr Reddy spearheads the Global Healthcare service delivery and is an honourable member of the World Economic Forum.

Independent Directors

M B N Rao is the lead independent director, and Vinayak Chatterjee, Murali Doraiswamy, V Kavitha Dutt, and Som Mittal are eminent independent directors on the board who oversee the corporate governance of the company and look into the interest of the investors and public.


The financials are audited by Deloitte Haskins & Sells LLP. It is one of the largest big4 accounting firm networks headquartered in England. They have been auditing the financials of the group from the financial year ending March 2017.

Market Capitalisation and Stock Information

Apollo Enterprise Ltd., went public in the year 1979. Consequently, it was listed in the NSE in January 1996, followed by BSE and several other exchanges. Since then, the stock has performed well and even stood out as the top performer in its peer groups in recent times. Let's look at some of the facts and figures:

●   The TTQ or Total Traded Quantity of its stock is 0.18 Lakhs.
●  The Face Value of shares is INR 5 each.
●  The stock is part of the S&P BSE 100 Index.

Shareholding Pattern

Out of the total stake, FIIs held 50.81%, Other Domestic Institutions 6.51%, Mutual Funds 5.94%, and Retail and Other investors held 7.41% of the company's equity shares.

The top mutual funds that have invested more than 2% of their AUM in the stock are Nippon India Pharma Fund, IDFC Balanced Advantage Fund, LIC MF Large Cap Fund and Sundaram Services Fund.

Corporate Social Responsibility Information

Steered by Dr Reddy, the founder and chairman of the group Apollo has been an exemplar in philanthropic collaborations and endeavours. The group's Total Health Cycle philosophy is: to 'screen, diagnose, treat, educate, and empower.' It successfully runs 3 philanthropic and humanitarian programs that aim at the economic and social prosperity of the underprivileged.

Total Health Program

This CSR model aims to enhance the mental, physical, social, ecological and spiritual health of individuals and the community at large. It directs its activities toward the society's comprehensive welfare and is mostly concentrated in the rural areas of Andhra Pradesh and Telangana.

Billion Hearts Beating Foundation

This non-profit organisation which runs several charitable projects for the elderly, public servants and healthcare workers, contributes by way of medicine supply and organisation of free healthcare camps for the beneficiaries. It also operates some critical care units in areas of public interest.

The SACHi Initiative

SACHi, on the other hand, is a child-focused non-profit initiative that fights for causes such as equal rights and quality healthcare for children. Over the years, it has provided free heart treatments, medicines and supplements to numerous children's homes and orphanages. It continues to pledge its services to touch the lives of many more children in the times to come.

Financial Information

Top Line

Over the last 5 years, the audited financial statements show a leap of INR 6420 crores in the Apollo group's total revenue. The revenue can be segregated as - 56% from core healthcare services and 9% from Apollo Health and Lifestyle, including Clinics, Diagnostic Centres, Dental, Dialysis and Fertility centres. Another 35% comes from the Pharmacy Distribution.

Bottom Line

On the other hand, the profit recorded has grown exponentially from Rs. 117 crores by a whopping 802.5% over the course of 5 years. The highest growth can be seen in the financial year 2021-22, when the bottom line grew 10 times. This can be attributed to a significant increase in revenue with a reduction in selling, general and administrative expenses.



Apollo Hospitals Enterprise FAQs

What is Share Price of Apollo Hospitals Enterprise ?

Apollo Hospitals Enterprise share price is ₹5,555 As on 09 December, 2023 | 00:20

What is the Market Cap of Apollo Hospitals Enterprise ?

The Market Cap of Apollo Hospitals Enterprise is ₹79877.4 Cr As on 09 December, 2023 | 00:20

What is the P/E ratio of Apollo Hospitals Enterprise ?

The P/E ratio of Apollo Hospitals Enterprise is 114.5 As on 09 December, 2023 | 00:20

What is the PB ratio of Apollo Hospitals Enterprise ?

The PB ratio of Apollo Hospitals Enterprise is 12.2 As on 09 December, 2023 | 00:20

What is the ROE of Apollo Hospitals Enterprise?

The ROE of Apollo Hospitals Enterprise is 3% which is fair but needs improvement.

When was Apollo Hospitals Enterprise founded?

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned as the architect of modern healthcare in India.

What is the stock price CAGR of Apollo Hospitals Enterprise?

The stock price CAGR of Apollo Hospitals Enterprise for 10 Years is 23%, 5 Years is 33%, 3 Years is 55%, 1 Year is 98%.

Is it a good time to invest in Apollo Hospital Enterprise?

Apollo Hospital Enterprise has an operating revenue of Rs. 13,105.07 Cr. on a trailing 12-month basis. Annual revenue de-growth of -6% needs improvement, Pre-tax margin of 2% needs improvement. The company has a debt to equity of 54%, which is a bit higher. Several analysts have a Buy rating on the stock.

How to buy Apollo Hospitals Enterprise Ltd. shares?

You can easily buy the shares of Apollo Hospitals Enterprise Ltd., by registering at 5Paisa and by setting up a Demat Account in your name.